NCT03838926
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03838926
Title Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanda Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL

Facility Status City State Zip Country Details
Vanda Investigational Site WITHDRAWN Washington D.C. District of Columbia 20007 United States Details
Vanda Investigational Site COMPLETED Lafayette Indiana 47905 United States Details
Vanda Investigational Site WITHDRAWN Hackensack New Jersey 07601 United States Details
Vanda Investigational Site COMPLETED Seattle Washington 98109 United States Details
Vanda Investigational Site RECRUITING Biała Podlaska Poland Details
Vanda Investigational Site RECRUITING Katowice Poland Details
Vanda Investigational Site RECRUITING Krakow Poland Details
Vanda Investigational Site RECRUITING Opole Poland Details
Vanda Investigational Site RECRUITING Skorzewo Poland Details
Vanda Investigational Site RECRUITING Warsaw Poland Details
Vanda Investigational Site RECRUITING Wroclaw Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field